●**The NKT cell system: bridging innate and acquired immunity.** Taniguchi, M., Seino, K. I. & Nakayama, T. [Nature Immunology](http://www.nature.com/ni/) December (2003).

●**HIV-1 dynamics** ***in vivo*** **: implications for therapy.** Simon, V. & Ho, D. D. *Nature Reviews Microbiology* December (2003).

●**A reprint supplement on RNAi will be distributed with the December issues of** ***Nature Reviews Molecular Cell Biology***, ***Nature Reviews Drug Discovery*** **and** ***Nature Reviews Genetics***. *The supplement --- sponsored by Qiagen --- contains six highlights, four reviews and a perspective, and is accompanied by a free web focus (*<http://www.nature.com/reviews/focus.rnai>)

●**The immune response of** ***Drosophila***. Hoffmann, J. A. [Nature](http://www.nature.com/nature/) 6 November (2003).

●**JAKing up immunosuppression.** Sykes, M. [Nature Medicine](http://www.nature.com/nm/) December (2003). *Discussion of a recent study in Science reporting a new immunosuppressive agent that specifically targets cytokine signalling through JAK3 in a primate model of kidney transplantation.*

●**Autoimmunity heats up.** Gelman, A. E. & Turka, L. A. [Nature Medicine](http://www.nature.com/nm/) December (2003). *This News & Views article discusses the role of heat-shock proteins in activating the immune system after a study showing that Hsp70 can trigger autoimmunity in a mouse model of diabetes.*

●**SARS --- beginning to understand a new virus.** Stadler, K. *et al*. *Nature Reviews Microbiology* December (2003). *This review looks at the genomics, phylogeny and antigen structure of the SARS-Coronavirus (SARS-CoV), together with the immune response to it and potential therapeutic interventions.*

●**Adjuvants and their signalling pathways: beyond TLRs.** Lien, E. & Golenbock, D. T. [Nature Immunology](http://www.nature.com/ni/) December (2003). *Microbial molecules that are ligands for TLRs, such as lipopolysaccharide (LPS) and poly(I:C), can act as adjuvants by enhancing the immune response to other antigens. This News & Views article looks at the different signalling pathways induced by LPS and poly(I:C) and their dependence on the adaptor protein TRIF/TICAM1.*

●**Fresh assualt on hepatitis C.** Rice, C. M. [Nature](http://www.nature.com/nature/) 13 November (2003). *Following on from the success of protease inhibitors in suppressing HIV replication, this News & Views article discusses recent promising trials of a drug that blocks a hepatitis C virus protease that is essential for replication. The drug BILN 2061 was found to cause a more rapid decrease in viral load than the present preferred therapy of interferon administration.*
